Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia

Deepak Chellapandian, Cameron L. Nicholson

Research output: Contribution to journalArticlepeer-review

Abstract

Myeloid neoplasms in children with sickle cell disease have been rarely reported, and the exact underlying connection between these two conditions is not clearly understood. Whether the acute myeloid leukemia in hydroxyurea-treated sickle cell patients is co-incidental or related to therapy remains an unanswered question. Herein, we report a 14-year-old girl of Haitian descent with sickle beta zero thalassemia on chronic hydroxyurea therapy who developed FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia and underwent a complete disease remission following a combination chemotherapy with sorafenib and was subsequently treated using a T cell replete unmanipulated haploidentical bone marrow transplantation followed by post-transplant cyclophosphamide.

Original languageEnglish (US)
Article numbere13641
JournalPediatric transplantation
Volume24
Issue number1
DOIs
StatePublished - Feb 1 2020

Keywords

  • acute myeloid leukemia
  • haploidentical transplantation with post-transplant cyclophosphamide
  • hydroxyurea therapy
  • sickle cell disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Fingerprint Dive into the research topics of 'Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this